Package 31722-304-31

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 31722-304-31
Digits Only 3172230431
Product NDC 31722-304
Product ID 31722-304_1bc57ba5-cc43-192b-e063-6394a90a0b53
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (31722-304-31) / 10 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-05-10
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

Decitabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "1bc57ba5-cc43-192b-e063-6394a90a0b53", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0331722304313"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["5662c353-05d0-4bd8-87e4-c92ec9ca861e"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (31722-304-31)  / 10 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "31722-304-31", "marketing_start_date": "20240510"}], "brand_name": "Decitabine", "product_id": "31722-304_1bc57ba5-cc43-192b-e063-6394a90a0b53", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "31722-304", "generic_name": "Decitabine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Decitabine", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/10mL"}], "application_number": "ANDA215355", "marketing_category": "ANDA", "marketing_start_date": "20240510", "listing_expiration_date": "20261231"}